The FDA Just Gave Oncolytics Biotech A Big Bump
February 11, 2015 at 14:36 PM EST
The FDA gave Orphan Drug Status to Oncolytics Biotech, Inc. (USA) (NASDAQ: ONCY)'s Ovarian Cancer drug, Reolysin, on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.